Endogenous opioid system in developing normal and jimpy oligodendrocytes: mu and kappa opioid receptors mediate differential mitogenic and growth responses.
about
Naloxone for reducing mortality and adverse neurological outcomes following acute traumatic brain injuryNaloxone for improving mortality and neurological outcomes following acute traumatic brain injurySystematic Review of Pharmacological Properties of the Oligodendrocyte LineageSynergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitroOpioid system diversity in developing neurons, astroglia, and oligodendroglia in the subventricular zone and striatum: impact on gliogenesis in vivoOpioid addiction and pregnancy: perinatal exposure to buprenorphine affects myelination in the developing brainUse of analgesic and sedative drugs in the NICU: integrating clinical trials and laboratory data.HIV-1 alters neural and glial progenitor cell dynamics in the central nervous system: coordinated response to opiates during maturation.Mu and kappa opioids modulate mouse embryonic stem cell-derived neural progenitor differentiation via MAP kinasesThe opioid system and brain development: effects of methadone on the oligodendrocyte lineage and the early stages of myelination.Pathobiology of dynorphins in trauma and disease.Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro.Selective vulnerability of cerebellar granule neuroblasts and their progeny to drugs with abuse liability.Glial-restricted precursors: patterns of expression of opioid receptors and relationship to human immunodeficiency virus-1 Tat and morphine susceptibility in vitro.Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.Oligodendrocyte responses to buprenorphine uncover novel and opposing roles of μ-opioid- and nociceptin/orphanin FQ receptors in cell development: implications for drug addiction treatment during pregnancyMorphine and gp120 toxic interactions in striatal neurons are dependent on HIV-1 strain.Neuropsychopharmacological understanding for therapeutic application of morphinansOpiate drug use and the pathophysiology of neuroAIDS.Functions of the chemokine receptor CXCR4 in the central nervous system and its regulation by μ-opioid receptors.Cell-specific loss of kappa-opioid receptors in oligodendrocytes of the dysmyelinating jimpy mouse.Trafficking of PLP/DM20 and cAMP signaling in immortalized jimpy oligodendrocytes.An immortalized jimpy oligodendrocyte cell line: defects in cell cycle and cAMP pathway.The protective effect of hydromorphone to ischemia in rat glial cellsHIV-1 Tat and morphine have interactive effects on oligodendrocyte survival and morphology.Transgenerational attenuation of opioid self-administration as a consequence of adolescent morphine exposure.Opioids intrinsically inhibit the genesis of mouse cerebellar granule neuron precursors in vitro: differential impact of mu and delta receptor activation on proliferation and neurite elongation.Endogenous opioids and oligodendroglial function: possible autocrine/paracrine effects on cell survival and development.Fetal alveolar epithelial cells contain [D-Ala(2)]-deltorphin I-like immunoreactivity: delta- and mu-opiate receptors mediate opposite effects in developing lung.A Novel Role for Oligodendrocyte Precursor Cells (OPCs) and Sox10 in Mediating Cellular and Behavioral Responses to Heroin.Opiate Drugs with Abuse Liability Hijack the Endogenous Opioid System to Disrupt Neuronal and Glial Maturation in the Central Nervous System.
P2860
Q24200756-C995E907-3E87-47EF-A4C2-35DBC12C8134Q24201499-DE0D2163-1DE4-418C-8413-E07637CEF52DQ26768210-725DE2F7-B127-4E5B-BC65-F97BD15FBD05Q28354326-95C6850D-4A20-4531-9CB2-210118DBD7A1Q28360384-173BB92C-855C-4200-9447-2A0B9E2E8DB0Q28565353-51437A6B-C07B-4731-B3AB-E6435FE9388DQ33525657-EC53C9C6-47C0-4155-9423-9CBAD8C60F08Q33647438-BA613599-E97C-4823-B71A-112286E86BBEQ33798722-88BF471D-170F-4F09-94AD-0A138487BA7AQ34244903-8093E26E-8DB1-4AF6-84FD-866F180CE714Q35007416-B937737C-EECB-464A-B734-398AAD375BB4Q35009483-9A67915C-3FB5-4CAF-843E-ACC48BFF3B3FQ35014175-582654B2-B8AB-4222-A50C-D67D42B19BFDQ35019404-558E0CF7-36BB-4F2C-9058-FA185A79AC41Q35122783-5331BC99-ADB8-4CA3-85CA-EB0EAA0DEE9AQ35552420-6E3299CB-0837-4701-BCB4-4733DB5D404AQ35857045-4605175D-0D53-41EA-8C89-919663002E09Q36102944-A6568E7E-EABC-4320-B5A7-2A6CEDE7EA7DQ36201412-853D0409-CEE2-44D5-A762-79E8E280DF4BQ38245110-A3D26A94-40E0-4DBF-BC1C-E713E5E0DAF7Q39832543-FC20193F-9F08-4814-90C6-FBA4DBB28D45Q40691684-6338CFB9-C85B-488F-B0E6-9AE651C91D64Q40804621-555B7D5C-1623-427A-B3E0-86C0DF3CC6E1Q41454933-E458D661-D0A8-4563-9A0F-473A9309A8CBQ41763649-E41A56AD-2FEA-4595-8A33-224078118585Q42073149-02E6B90D-2C85-4A21-9FAF-49964A04085DQ43119443-EC5E4C29-2F35-4630-BEF5-E4B12E21F449Q43680252-EC7B7BF2-F7F9-4897-B494-D28EABE178FDQ43789207-2B06C2E3-37EC-4F6A-AF03-9A1768E9C7E0Q47278358-A6542D03-06D5-432D-82DD-BE34A0A50B6AQ49270407-A5A1D289-3E92-4BCB-92CF-2763B9A7EB81
P2860
Endogenous opioid system in developing normal and jimpy oligodendrocytes: mu and kappa opioid receptors mediate differential mitogenic and growth responses.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Endogenous opioid system in de ...... itogenic and growth responses.
@en
Endogenous opioid system in de ...... itogenic and growth responses.
@nl
type
label
Endogenous opioid system in de ...... itogenic and growth responses.
@en
Endogenous opioid system in de ...... itogenic and growth responses.
@nl
prefLabel
Endogenous opioid system in de ...... itogenic and growth responses.
@en
Endogenous opioid system in de ...... itogenic and growth responses.
@nl
P2093
P2860
P1433
P1476
Endogenous opioid system in de ...... itogenic and growth responses.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1098-1136(199802)22:2<189::AID-GLIA10>3.0.CO;2-U
P577
1998-02-01T00:00:00Z